SHIFT AI Newsroom · GLOBAL

Semaglutide Shows Promise in Treating Prurigo Nodularis

A recent case report published on Europe PMC highlights the dramatic improvement of treatment-refractory prurigo nodularis following the initiation of semaglutide.

Published 2026-09-10 · Evidence level 2

A recent case report published on Europe PMC highlights the dramatic improvement of treatment-refractory prurigo nodularis following the initiation of semaglutide. This new evidence may be relevant to UK patients suffering from prurigo nodularis, as it potentially offers an alternative treatment option.

What this means in the UK

This new information may be relevant to UK patients suffering from prurigo nodularis, as it potentially offers an alternative treatment option.

Known facts

  • Semaglutide has shown dramatic improvement in treating treatment-refractory prurigo nodularis in a case report.

Sources and evidence

← Back to SHIFT AI Newsroom